Drug-Drug Interactions of Newly Approved Direct-Acting Antiviral Agents in Patients with Hepatitis C.  Gao LH, Nie QH, Zhao XT.  Int J Gen Med. 2021 Jan 28;14:289-301. doi: 10.2147/IJGM.S283910. PMID: 33536776; PMCID: PMC7850569. http...

Methadone, Metoclopramide and Metronidazole Interaction Causing Torsades de Pointes.  Gnanapandithan K, Karthik N, Gerber J.  Clin Pract. 2021 Feb 7;11(1):101-105. doi: 10.3390/clinpract11010015. PMID: 33562182; PMCID: PMC7931031. htt...

Comparison of two algorithms to support medication surveillance for drug-drug interactions between QTc-prolonging drugs.  Berger FA, van der Sijs H, van Gelder T, Kuijper AFM, van den Bemt PMLA, Becker ML.  Int J Med Inform. 2021 Jan;1...

Review of Clinically Relevant Drug Interactions with Next Generation Hepatitis C Direct-acting Antiviral Agents.  Hong J, Wright RC, Partovi N, Yoshida EM, Hussaini T.  J Clin Transl Hepatol. 2020 Sep 28;8(3):322-335. doi: 10.14218/JCT...

Clinically Significant Drug-Drug Interaction Between Methadone and Cannabidiol.  Madden K, Tanco K, Bruera E. Clinically  Pediatrics. 2020;145(6):e20193256. doi:10.1542/peds.2019-3256 Abstract https://pubmed.ncbi.nlm.nih.gov/32444381/

Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions. Brown, J.D.  J. Clin. Med. 2020, 9, 919. https://www.mdpi.com/2077-0383/9/4/919/htm